Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Wade

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1993
Effect of misspecification of the absorption process on subsequent parameter estimation in population analysisJ R Wade, A W Kelman, C A Howie, et al.
British Journal of Clinical Pharmacology|February 1, 1992
The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in manJ R Wade, P A Meredith, D M Hughes, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 31, 1998
Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patientsM O Karlsson, E N Jonsson, C G Wiltse, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 16, 2013
Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE StudiesP Jacqmin, J R Wade, B Weatherley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Variability in the pharmacokinetics of epirubicin: a population analysisJ R Wade, A W Kelman, D J Kerr, et al.
British Journal of Clinical Pharmacology|September 1, 1993
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalaprilN J Macdonald, A Sioufi, C A Howie, et al.
Journal of Pharmaceutical Sciences|May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilatJ R Wade, D M Hughes, A W Kelman, et al.
Journal of the American Veterinary Medical Association|December 15, 1994
Facts about ratitesK D Hicks-Alldredge, B E Alldredge, B L Speer, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patientsT N Kakuda, J R Wade, E Snoeck, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1993
Effect of misspecification of the absorption process on subsequent parameter estimation in population analysisJ R Wade, A W Kelman, C A Howie, et al.
British Journal of Clinical Pharmacology|February 1, 1992
The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in manJ R Wade, P A Meredith, D M Hughes, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 31, 1998
Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patientsM O Karlsson, E N Jonsson, C G Wiltse, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 16, 2013
Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE StudiesP Jacqmin, J R Wade, B Weatherley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Variability in the pharmacokinetics of epirubicin: a population analysisJ R Wade, A W Kelman, D J Kerr, et al.
British Journal of Clinical Pharmacology|September 1, 1993
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalaprilN J Macdonald, A Sioufi, C A Howie, et al.
Journal of Pharmaceutical Sciences|May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilatJ R Wade, D M Hughes, A W Kelman, et al.
Journal of the American Veterinary Medical Association|December 15, 1994
Facts about ratitesK D Hicks-Alldredge, B E Alldredge, B L Speer, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patientsT N Kakuda, J R Wade, E Snoeck, et al.
Pageof 2